Pub Date : 2024-10-15DOI: 10.7499/j.issn.1008-8830.2405054
Ming-Xin Huang, Qing Yu, Yuan-Yuan Li
Objectives: To explore the application of neurofeedback (NFB) combined with learning style profile (LSP) intervention training in children with high-functioning autism (HFA).
Methods: A prospective study was conducted to select 86 children with HFA admitted to the hospital from February 2022 to February 2024. They were divided into two groups according to the random number table method, with 43 cases in each group. In this double-blind study, the control group was given LSP intervention training, and the observation group was given NFB intervention on the basis of the treatment used in the control group. Both groups were treated for 6 months. The scores of Autism Behavior Checklist (ABC), Autism Treatment Evaluation Checklist (ATEC), Social Responsiveness Scale (SRS), and Pediatric Quality of Life (PedsQL) were compared between the two groups before intervention and at 6 months after intervention. The relationship of PedsQL score with ABC, ATEC, and SRS scores was analyzed in children with HFA.
Results: After 6 months of intervention, the scores of ABC, ATEC, and SRS in the observation group were significantly lower than those in the control group, while the PedsQL score in the observation group was significantly higher than that in the control group (P<0.05). The PedsQL score was negatively correlated with the ABC, ATEC, and SRS scores in children with HFA (r=-0.238, -0.381, -0.219 respectively; P<0.001).
Conclusions: NFB combined with LSP can effectively improve the clinical symptoms and social ability, control the development of the disease, and improve the quality of life in children with HFA.
{"title":"[A prospective randomized controlled study of neurofeedback combined with learning style profile intervention training in children with high-functioning autism].","authors":"Ming-Xin Huang, Qing Yu, Yuan-Yuan Li","doi":"10.7499/j.issn.1008-8830.2405054","DOIUrl":"10.7499/j.issn.1008-8830.2405054","url":null,"abstract":"<p><strong>Objectives: </strong>To explore the application of neurofeedback (NFB) combined with learning style profile (LSP) intervention training in children with high-functioning autism (HFA).</p><p><strong>Methods: </strong>A prospective study was conducted to select 86 children with HFA admitted to the hospital from February 2022 to February 2024. They were divided into two groups according to the random number table method, with 43 cases in each group. In this double-blind study, the control group was given LSP intervention training, and the observation group was given NFB intervention on the basis of the treatment used in the control group. Both groups were treated for 6 months. The scores of Autism Behavior Checklist (ABC), Autism Treatment Evaluation Checklist (ATEC), Social Responsiveness Scale (SRS), and Pediatric Quality of Life (PedsQL) were compared between the two groups before intervention and at 6 months after intervention. The relationship of PedsQL score with ABC, ATEC, and SRS scores was analyzed in children with HFA.</p><p><strong>Results: </strong>After 6 months of intervention, the scores of ABC, ATEC, and SRS in the observation group were significantly lower than those in the control group, while the PedsQL score in the observation group was significantly higher than that in the control group (<i>P</i><0.05). The PedsQL score was negatively correlated with the ABC, ATEC, and SRS scores in children with HFA (<i>r</i>=-0.238, -0.381, -0.219 respectively; <i>P</i><0.001).</p><p><strong>Conclusions: </strong>NFB combined with LSP can effectively improve the clinical symptoms and social ability, control the development of the disease, and improve the quality of life in children with HFA.</p>","PeriodicalId":39792,"journal":{"name":"中国当代儿科杂志","volume":"26 10","pages":"1066-1071"},"PeriodicalIF":0.0,"publicationDate":"2024-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11527408/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142523295","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-10-15DOI: 10.7499/j.issn.1008-8830.2402079
Wen-Feng Fu, Yong-Jun Fang
Objectives: To explore the clinical characteristics of children with acute T-lymphoblastic leukemia (T-ALL) and analyze their relationship with prognosis.
Methods: A retrospective analysis was conducted on the clinical data and follow-up results of 50 children with T-ALL who were treated using the CCCG-ALL-2015 protocol at the Department of Hematology and Oncology, Children's Hospital of Nanjing Medical University from November 2015 to December 2019. Kaplan-Meier survival analysis and Cox regression analysis were employed to identify factors affecting prognosis.
Results: Among the 50 T-ALL patients, there were 7 cases of relapse. There was no statistically significant difference in the baseline clinical data between the relapse group and the non-relapse group (P>0.05). However, the positive rate of minimal residual disease (MRD) (≥0.01%) on day 46 after induction remission therapy in the relapse group was significantly higher than that in the non-relapse group (P=0.037). The 5-year overall survival rate for the 50 patients was (87±5)%, and the 5-year event-free survival rate was (86±5)%. Multivariate Cox regression analysis indicated that the MRD level on day 46 after induction remission therapy was an independent prognostic factor (HR=0.104, 95%CI: 0.015-0.740, P=0.024).
Conclusions: MRD is of significant importance for the prognosis of T-ALL children. Personalized treatment should be provided based on MRD levels to prevent relapse and improve prognosis in these patients.
{"title":"[Prognostic factors in children with acute T-lymphoblastic leukemia: a single-center clinical study of the CCCG-ALL-2015 protocol].","authors":"Wen-Feng Fu, Yong-Jun Fang","doi":"10.7499/j.issn.1008-8830.2402079","DOIUrl":"10.7499/j.issn.1008-8830.2402079","url":null,"abstract":"<p><strong>Objectives: </strong>To explore the clinical characteristics of children with acute T-lymphoblastic leukemia (T-ALL) and analyze their relationship with prognosis.</p><p><strong>Methods: </strong>A retrospective analysis was conducted on the clinical data and follow-up results of 50 children with T-ALL who were treated using the CCCG-ALL-2015 protocol at the Department of Hematology and Oncology, Children's Hospital of Nanjing Medical University from November 2015 to December 2019. Kaplan-Meier survival analysis and Cox regression analysis were employed to identify factors affecting prognosis.</p><p><strong>Results: </strong>Among the 50 T-ALL patients, there were 7 cases of relapse. There was no statistically significant difference in the baseline clinical data between the relapse group and the non-relapse group (<i>P</i>>0.05). However, the positive rate of minimal residual disease (MRD) (≥0.01%) on day 46 after induction remission therapy in the relapse group was significantly higher than that in the non-relapse group (<i>P</i>=0.037). The 5-year overall survival rate for the 50 patients was (87±5)%, and the 5-year event-free survival rate was (86±5)%. Multivariate Cox regression analysis indicated that the MRD level on day 46 after induction remission therapy was an independent prognostic factor (<i>HR</i>=0.104, 95%<i>CI</i>: 0.015-0.740, <i>P</i>=0.024).</p><p><strong>Conclusions: </strong>MRD is of significant importance for the prognosis of T-ALL children. Personalized treatment should be provided based on MRD levels to prevent relapse and improve prognosis in these patients.</p>","PeriodicalId":39792,"journal":{"name":"中国当代儿科杂志","volume":"26 10","pages":"1078-1085"},"PeriodicalIF":0.0,"publicationDate":"2024-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11527409/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142523319","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-10-15DOI: 10.7499/j.issn.1008-8830.2406014
Wen-Jing Qi, Xue-Ju Xu, Bai Li, Tao Wang, Guang-Yao Sheng, Ping Zhu, Chun-Mei Wang
Objectives: To explore the current application of high-throughput drug sensitivity (HDS) testing in children with relapsed and refractory acute leukemia (RR-AL) and analyze the feasibility of salvage treatment plans.
Methods: A retrospective collection of clinical data from children with RR-AL who underwent HDS testing at the Department of Children's Hematology and Oncology of the First Affiliated Hospital of Zhengzhou University from November 2021 to October 2023 was conducted, followed by an analysis of drug sensitivity results and treatment outcomes.
Results: A total of 17 children with RR-AL underwent HDS testing, including 7 cases of relapsed refractory acute myeloid leukemia and 10 cases of relapsed refractory acute lymphoblastic leukemia. The detection rate of highly sensitive chemotherapy drugs/regimens was 53% (9/17), while the detection rate of moderately sensitive chemotherapy drugs/regimens was 100% (17/17). Among the 17 RR-AL patients with highly and moderately sensitive chemotherapy drugs and regimens, the MOACD regimen (mitoxantrone + vincristine + cytarabine + cyclophosphamide + dexamethasone) accounted for 100%, with the highest inhibition rate for single-agent mitoxantrone (94%, 16/17), and the highest inhibition rate for targeted therapy being bortezomib (94%, 16/17). Nine patients adjusted their chemotherapy based on HDS testing results, with 4 undergoing hematopoietic stem cell transplantation. Four patients achieved disease-free survival, while 5 died. Eight patients received empirical chemotherapy, with 2 undergoing hematopoietic stem cell transplantation; 4 achieved disease-free survival, while 4 died.
Conclusions: HDS testing can identify highly sensitive drugs/regimens for children with RR-AL, improving the rate of re-remission and creating conditions for subsequent hematopoietic stem cell transplantation.
{"title":"[Application of high-throughput drug sensitivity testing in children with relapsed and refractory acute leukemia].","authors":"Wen-Jing Qi, Xue-Ju Xu, Bai Li, Tao Wang, Guang-Yao Sheng, Ping Zhu, Chun-Mei Wang","doi":"10.7499/j.issn.1008-8830.2406014","DOIUrl":"10.7499/j.issn.1008-8830.2406014","url":null,"abstract":"<p><strong>Objectives: </strong>To explore the current application of high-throughput drug sensitivity (HDS) testing in children with relapsed and refractory acute leukemia (RR-AL) and analyze the feasibility of salvage treatment plans.</p><p><strong>Methods: </strong>A retrospective collection of clinical data from children with RR-AL who underwent HDS testing at the Department of Children's Hematology and Oncology of the First Affiliated Hospital of Zhengzhou University from November 2021 to October 2023 was conducted, followed by an analysis of drug sensitivity results and treatment outcomes.</p><p><strong>Results: </strong>A total of 17 children with RR-AL underwent HDS testing, including 7 cases of relapsed refractory acute myeloid leukemia and 10 cases of relapsed refractory acute lymphoblastic leukemia. The detection rate of highly sensitive chemotherapy drugs/regimens was 53% (9/17), while the detection rate of moderately sensitive chemotherapy drugs/regimens was 100% (17/17). Among the 17 RR-AL patients with highly and moderately sensitive chemotherapy drugs and regimens, the MOACD regimen (mitoxantrone + vincristine + cytarabine + cyclophosphamide + dexamethasone) accounted for 100%, with the highest inhibition rate for single-agent mitoxantrone (94%, 16/17), and the highest inhibition rate for targeted therapy being bortezomib (94%, 16/17). Nine patients adjusted their chemotherapy based on HDS testing results, with 4 undergoing hematopoietic stem cell transplantation. Four patients achieved disease-free survival, while 5 died. Eight patients received empirical chemotherapy, with 2 undergoing hematopoietic stem cell transplantation; 4 achieved disease-free survival, while 4 died.</p><p><strong>Conclusions: </strong>HDS testing can identify highly sensitive drugs/regimens for children with RR-AL, improving the rate of re-remission and creating conditions for subsequent hematopoietic stem cell transplantation.</p>","PeriodicalId":39792,"journal":{"name":"中国当代儿科杂志","volume":"26 10","pages":"1093-1100"},"PeriodicalIF":0.0,"publicationDate":"2024-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11527403/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142523297","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Objectives: To investigate the clinical features and prognosis of children with fungal bloodstream infection (BSI) following chemotherapy for acute leukemia (AL).
Methods: A retrospective analysis was performed on 23 children with fungal BSI following chemotherapy for AL in three hospitals in Fujian Province, China, from January 2015 to December 2023. Their clinical features and prognosis were analyzed.
Results: Among all children following chemotherapy for AL, the incidence rate of fungal BSI was 1.38% (23/1 668). At the time of fungal BSI, 87% (20/23) of the children had neutrophil deficiency for more than one week, and all the children presented with fever, while 22% (5/23) of them experienced septic shock. All 23 children exhibited significant increases in C-reactive protein and procalcitonin levels. A total of 23 fungal isolates were detected in peripheral blood cultures, with Candida tropicalis being the most common isolate (52%, 12/23). Caspofungin or micafungin combined with liposomal amphotericin B had a relatively high response rate (75%, 12/16), and the median duration of antifungal therapy was 3.0 months. The overall mortality rate in the patients with fungal BSI was 35% (8/23), and the attributable death rate was 22% (5/23).
Conclusions: Fungal BSI following chemotherapy in children with AL often occurs in children with persistent neutrophil deficiency and lacks specific clinical manifestations. The children with fungal BSI following chemotherapy for AL experience a prolonged course of antifungal therapy and have a high mortality rate, with Candida tropicalis being the most common pathogen.
目的研究急性白血病(AL)化疗后真菌血流感染(BSI)患儿的临床特征和预后:方法:对2015年1月至2023年12月期间福建省三家医院收治的23名急性白血病化疗后真菌BSI患儿进行回顾性分析。结果:在所有接受AL化疗的患儿中,真菌性BSI的发生率最高:在所有接受AL化疗的患儿中,真菌BSI的发生率为1.38%(23/1668)。发生真菌性 BSI 时,87%(20/23)的患儿中性粒细胞缺乏超过一周,所有患儿均出现发热,22%(5/23)的患儿出现脓毒性休克。所有23名患儿的C反应蛋白和降钙素原水平均明显升高。外周血培养中共检测到 23 种真菌分离物,其中热带念珠菌是最常见的分离物(52%,12/23)。卡泊芬净或米卡芬净联合两性霉素 B 脂质体的应答率相对较高(75%,12/16),抗真菌治疗的中位持续时间为 3.0 个月。真菌BSI患者的总死亡率为35%(8/23),可归因死亡率为22%(5/23):结论:AL患儿化疗后真菌性BSI通常发生在中性粒细胞持续缺乏的患儿中,且缺乏特异性临床表现。AL化疗后真菌BSI患儿的抗真菌治疗疗程较长,死亡率较高,热带念珠菌是最常见的病原体。
{"title":"[Clinical features and prognosis of children with fungal bloodstream infection following chemotherapy for acute leukemia].","authors":"Kai-Zhi Weng, Chun-Ping Wu, Shu-Quan Zhuang, Shu-Xian Huang, Xiao-Fang Wang, Yong-Zhi Zheng","doi":"10.7499/j.issn.1008-8830.2406021","DOIUrl":"10.7499/j.issn.1008-8830.2406021","url":null,"abstract":"<p><strong>Objectives: </strong>To investigate the clinical features and prognosis of children with fungal bloodstream infection (BSI) following chemotherapy for acute leukemia (AL).</p><p><strong>Methods: </strong>A retrospective analysis was performed on 23 children with fungal BSI following chemotherapy for AL in three hospitals in Fujian Province, China, from January 2015 to December 2023. Their clinical features and prognosis were analyzed.</p><p><strong>Results: </strong>Among all children following chemotherapy for AL, the incidence rate of fungal BSI was 1.38% (23/1 668). At the time of fungal BSI, 87% (20/23) of the children had neutrophil deficiency for more than one week, and all the children presented with fever, while 22% (5/23) of them experienced septic shock. All 23 children exhibited significant increases in C-reactive protein and procalcitonin levels. A total of 23 fungal isolates were detected in peripheral blood cultures, with <i>Candida tropicalis</i> being the most common isolate (52%, 12/23). Caspofungin or micafungin combined with liposomal amphotericin B had a relatively high response rate (75%, 12/16), and the median duration of antifungal therapy was 3.0 months. The overall mortality rate in the patients with fungal BSI was 35% (8/23), and the attributable death rate was 22% (5/23).</p><p><strong>Conclusions: </strong>Fungal BSI following chemotherapy in children with AL often occurs in children with persistent neutrophil deficiency and lacks specific clinical manifestations. The children with fungal BSI following chemotherapy for AL experience a prolonged course of antifungal therapy and have a high mortality rate, with <i>Candida tropicalis</i> being the most common pathogen.</p>","PeriodicalId":39792,"journal":{"name":"中国当代儿科杂志","volume":"26 10","pages":"1086-1092"},"PeriodicalIF":0.0,"publicationDate":"2024-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11527414/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142523313","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
<p><strong>Objectives: </strong>To evaluate the preventive effects of <i>Saccharomyces boulardii</i> powder and tetragenous viable <i>Bifidobacterium</i> tablets on antibiotic-associated diarrhea (AAD) in infants and young children.</p><p><strong>Methods: </strong>Children under three years old admitted to the Department of Pediatrics, Affiliated Hospital of Xuzhou Medical University due to non-gastrointestinal infections and requiring antibiotic treatment from July to December 2023 were enrolled. The children were randomly divided into a control group (<i>n</i>=47), a <i>Saccharomyces boulardii</i> group (<i>n</i>=70), and a <i>Bifidobacterium</i> group (<i>n</i>=65) using a random number table method. The control group received antibiotics and symptomatic supportive treatment according to relevant clinical guidelines. In addition to the treatment given to the control group, the <i>Saccharomyces boulardii</i> group and the <i>Bifidobacterium</i> group were respectively administered with <i>Saccharomyces boulardii</i> powder and tetragenous viable <i>Bifidobacterium</i> tablets. Based on the duration of probiotic use (7 days, 14 days, and 21 days), the <i>Saccharomyces boulardii</i> group was further divided into 7 d, 14 d, and 21 d subgroups, and similarly for the <i>Bifidobacterium</i> group. The incidence of AAD and ratio of cocci to bacilli in feces were compared among the groups after treatment.</p><p><strong>Results: </strong>The incidence rate of AAD in both the <i>Saccharomyces boulardii</i> group and the <i>Bifidobacterium</i> group was lower than that in the control group (<i>P</i><0.017). The duration of AAD and the length of hospital stay were shorter in the <i>Saccharomyces boulardii</i> and <i>Bifidobacterium</i> groups compared to the control group (<i>P</i><0.05). In the control group, the ratio of cocci to bacilli in feces on days 7, 14, and 21 was higher than on day 1 (<i>P</i><0.05). Within-group comparisons showed that the ratio of cocci to bacilli in feces on day 14 in the <i>Bifidobacterium</i> 14 d and 21 d groups were lower than on day 1 (<i>P</i><0.05); and the ratios on day 14 in the control group, <i>Saccharomyces boulardii</i> 14 d group, <i>Saccharomyces boulardii</i> 21 d group, <i>Bifidobacterium</i> 14 d group, and <i>Bifidobacterium</i> 21 d group were lower than on day 7 (<i>P</i><0.05). The ratios on day 21 in the control group and the <i>Saccharomyces boulardii</i> 21 d group were lower than on days 7 and 14 (<i>P</i><0.05). Between-group comparisons indicated that on day 7, the ratios of cocci to bacilli in feces in the <i>Saccharomyces boulardii</i> 7 d, 14 d, 21 d groups, and <i>Bifidobacterium</i> 7 d, 14 d, 21 d groups were all lower than in the control group (<i>P</i><0.05); on day 14, the ratios of cocci to bacilli in feces 14 d and 21 d groups were lower than in the control group and the <i>Bifidobacterium</i> 7 d group (<i>P</i><0.05).</p><p><strong>Conclusions: </strong>Both <i>Saccharomyces boulardii
目的评估布拉氏酵母菌粉和四元双歧杆菌片对婴幼儿抗生素相关性腹泻(AAD)的预防效果:方法:选取2023年7月至12月在徐州医科大学附属医院儿科就诊的因非消化道感染而需要抗生素治疗的3岁以下婴幼儿为研究对象。采用随机数字表法将患儿随机分为对照组(47 人)、布拉氏酵母菌组(70 人)和双歧杆菌组(65 人)。对照组根据相关临床指南接受抗生素和对症支持治疗。布拉氏酵母菌组和双歧杆菌组除了接受对照组的治疗外,还分别服用布拉氏酵母菌粉和四源双歧杆菌片剂。根据使用益生菌的时间(7 天、14 天和 21 天),布拉氏酵母菌组又分为 7 天、14 天和 21 天三个亚组,双歧杆菌组也是如此。比较各组治疗后 AAD 的发生率和粪便中球菌与杆菌的比例:结果:布拉氏酵母菌组和双歧杆菌组的AAD发病率均低于对照组(布拉氏酵母菌组和双歧杆菌组与对照组相比,布拉氏酵母菌14 d组和双歧杆菌21 d组的AAD发病率均低于第1天(布拉氏酵母菌14 d组,布拉氏酵母菌21 d组,双歧杆菌14 d组,布拉氏酵母菌21 d组)、双歧杆菌 14 d 组和双歧杆菌 21 d 组均低于第 7 天(布拉氏酵母菌 21 d 组),低于第 7 天和第 14 天(布拉氏酵母菌 7 d 组、布拉氏酵母菌 14 d 组和双歧杆菌 21 d 组均低于第 7 天和第 14 天),低于对照组(双歧杆菌 7 d 组、双歧杆菌 14 d 组和双歧杆菌 21 d 组均低于第 7 天和第 14 天):布拉氏酵母菌和四元双歧杆菌都能有效改善肠道微生物群,预防婴幼儿AAD的发生。与短期治疗相比,适当延长益生菌治疗时间可进一步改善肠道微生物群的结构。
{"title":"[A prospective randomized controlled study on probiotics for the prevention of antibiotic-associated diarrhea in infants and young children].","authors":"Su-Wei Zhang, Xian Zhi, Meng-Yu Wang, Dong-Lin Shen","doi":"10.7499/j.issn.1008-8830.2401129","DOIUrl":"10.7499/j.issn.1008-8830.2401129","url":null,"abstract":"<p><strong>Objectives: </strong>To evaluate the preventive effects of <i>Saccharomyces boulardii</i> powder and tetragenous viable <i>Bifidobacterium</i> tablets on antibiotic-associated diarrhea (AAD) in infants and young children.</p><p><strong>Methods: </strong>Children under three years old admitted to the Department of Pediatrics, Affiliated Hospital of Xuzhou Medical University due to non-gastrointestinal infections and requiring antibiotic treatment from July to December 2023 were enrolled. The children were randomly divided into a control group (<i>n</i>=47), a <i>Saccharomyces boulardii</i> group (<i>n</i>=70), and a <i>Bifidobacterium</i> group (<i>n</i>=65) using a random number table method. The control group received antibiotics and symptomatic supportive treatment according to relevant clinical guidelines. In addition to the treatment given to the control group, the <i>Saccharomyces boulardii</i> group and the <i>Bifidobacterium</i> group were respectively administered with <i>Saccharomyces boulardii</i> powder and tetragenous viable <i>Bifidobacterium</i> tablets. Based on the duration of probiotic use (7 days, 14 days, and 21 days), the <i>Saccharomyces boulardii</i> group was further divided into 7 d, 14 d, and 21 d subgroups, and similarly for the <i>Bifidobacterium</i> group. The incidence of AAD and ratio of cocci to bacilli in feces were compared among the groups after treatment.</p><p><strong>Results: </strong>The incidence rate of AAD in both the <i>Saccharomyces boulardii</i> group and the <i>Bifidobacterium</i> group was lower than that in the control group (<i>P</i><0.017). The duration of AAD and the length of hospital stay were shorter in the <i>Saccharomyces boulardii</i> and <i>Bifidobacterium</i> groups compared to the control group (<i>P</i><0.05). In the control group, the ratio of cocci to bacilli in feces on days 7, 14, and 21 was higher than on day 1 (<i>P</i><0.05). Within-group comparisons showed that the ratio of cocci to bacilli in feces on day 14 in the <i>Bifidobacterium</i> 14 d and 21 d groups were lower than on day 1 (<i>P</i><0.05); and the ratios on day 14 in the control group, <i>Saccharomyces boulardii</i> 14 d group, <i>Saccharomyces boulardii</i> 21 d group, <i>Bifidobacterium</i> 14 d group, and <i>Bifidobacterium</i> 21 d group were lower than on day 7 (<i>P</i><0.05). The ratios on day 21 in the control group and the <i>Saccharomyces boulardii</i> 21 d group were lower than on days 7 and 14 (<i>P</i><0.05). Between-group comparisons indicated that on day 7, the ratios of cocci to bacilli in feces in the <i>Saccharomyces boulardii</i> 7 d, 14 d, 21 d groups, and <i>Bifidobacterium</i> 7 d, 14 d, 21 d groups were all lower than in the control group (<i>P</i><0.05); on day 14, the ratios of cocci to bacilli in feces 14 d and 21 d groups were lower than in the control group and the <i>Bifidobacterium</i> 7 d group (<i>P</i><0.05).</p><p><strong>Conclusions: </strong>Both <i>Saccharomyces boulardii","PeriodicalId":39792,"journal":{"name":"中国当代儿科杂志","volume":"26 10","pages":"1108-1114"},"PeriodicalIF":0.0,"publicationDate":"2024-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11527406/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142523296","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-10-15DOI: 10.7499/j.issn.1008-8830.2406037
Ling-Zi Yao, De-Nan Jiang, Jing Wu, Guang-Dian Shen, Jin Cao, Si-Qing Cheng, Shi-Yi Shan, Ze-Yu Luo, Jia-Li Zhou, Pei-Ge Song
Objectives: To investigate the prevalence of tension-type headache (TTH) in children and adolescents aged 0-19 years globally in 1990-2021, and to provide a basis for the prevention and treatment of TTH.
Methods: Based on the Global Burden of Disease Study data, the age-standardized prevalence distribution of TTH and its changing trend were analyzed among the children and adolescents aged 0-19 years, with different sexes, age groups, sociodemographic index (SDI) regions and countries/territories.
Results: The age-standardized prevalence rate (ASPR) of TTH in children and adolescents aged 0-19 globally in 2021 was 17 339.89/100 000, which was increased by 1.73% since 1990. The ASPR in females was slightly higher than that in males (1990: 17 707.65/100 000 vs 16 403.78/100 000; 2021: 17 946.29/100 000 vs 16 763.09/100 000). The ASPR in adolescence was significantly higher than that in school-aged and preschool periods (1990: 27 672.04/100 000 vs 10 134.16/100 000; 2021: 28 239.04/100 000 vs 10 059.39/100 000). Regions with high SDI exhibited a higher ASPR than the other regions, with significant differences in prevalence rates across different countries. From 1990 to 2021, there was a slight increase in global ASPR, with an average annual percentage change (AAPC) of 0.06%. Females experienced a smaller increase than males based on AAPC (0.04% vs 0.07%). There was reduction in ASPR in preschool and school-aged groups, with an AAPC of -0.02%, while there was a significant increase in ASPR in adolescence, with an AAPC of 0.07%. ASPR decreased in regions with low-middle and low levels of SDI, with an AAPC of -0.02% and -0.04%, respectively, while it increased in regions with middle SDI, with an AAPC of 0.24%.
Conclusions: There is a consistent increase in the ASPR of TTH in children and adolescents aged 0-19 years globally, with significant differences across sexes, age groups, SDI regions and countries/territories.
{"title":"[Temporal trend of the global prevalence rate of tension-type headache in children and adolescents in 1990-2021].","authors":"Ling-Zi Yao, De-Nan Jiang, Jing Wu, Guang-Dian Shen, Jin Cao, Si-Qing Cheng, Shi-Yi Shan, Ze-Yu Luo, Jia-Li Zhou, Pei-Ge Song","doi":"10.7499/j.issn.1008-8830.2406037","DOIUrl":"10.7499/j.issn.1008-8830.2406037","url":null,"abstract":"<p><strong>Objectives: </strong>To investigate the prevalence of tension-type headache (TTH) in children and adolescents aged 0-19 years globally in 1990-2021, and to provide a basis for the prevention and treatment of TTH.</p><p><strong>Methods: </strong>Based on the Global Burden of Disease Study data, the age-standardized prevalence distribution of TTH and its changing trend were analyzed among the children and adolescents aged 0-19 years, with different sexes, age groups, sociodemographic index (SDI) regions and countries/territories.</p><p><strong>Results: </strong>The age-standardized prevalence rate (ASPR) of TTH in children and adolescents aged 0-19 globally in 2021 was 17 339.89/100 000, which was increased by 1.73% since 1990. The ASPR in females was slightly higher than that in males (1990: 17 707.65/100 000 vs 16 403.78/100 000; 2021: 17 946.29/100 000 vs 16 763.09/100 000). The ASPR in adolescence was significantly higher than that in school-aged and preschool periods (1990: 27 672.04/100 000 vs 10 134.16/100 000; 2021: 28 239.04/100 000 vs 10 059.39/100 000). Regions with high SDI exhibited a higher ASPR than the other regions, with significant differences in prevalence rates across different countries. From 1990 to 2021, there was a slight increase in global ASPR, with an average annual percentage change (AAPC) of 0.06%. Females experienced a smaller increase than males based on AAPC (0.04% vs 0.07%). There was reduction in ASPR in preschool and school-aged groups, with an AAPC of -0.02%, while there was a significant increase in ASPR in adolescence, with an AAPC of 0.07%. ASPR decreased in regions with low-middle and low levels of SDI, with an AAPC of -0.02% and -0.04%, respectively, while it increased in regions with middle SDI, with an AAPC of 0.24%.</p><p><strong>Conclusions: </strong>There is a consistent increase in the ASPR of TTH in children and adolescents aged 0-19 years globally, with significant differences across sexes, age groups, SDI regions and countries/territories.</p>","PeriodicalId":39792,"journal":{"name":"中国当代儿科杂志","volume":"26 10","pages":"1058-1065"},"PeriodicalIF":0.0,"publicationDate":"2024-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11527401/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142523322","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-10-15DOI: 10.7499/j.issn.1008-8830.2404029
Dan Yao, Fang-Fang Li, Ji-Yang Shen, Wei-Jun Chen, Chai Ji
Objectives: To investigate the early cognitive development characteristics of children with Williams syndrome (WS) at different age stages.
Methods: From September 2018 to June 2023, 106 children diagnosed with WS at the Department of Pediatric Health Care, Children's Hospital, Zhejiang University School of Medicine, aged 1 to <5 years, were prospectively enrolled. All children underwent Gesell developmental diagnostic assessments to analyze the cognitive development characteristics of WS children across different age groups.
Results: The average age of the 106 WS children was (3.1±1.2) years; 58 were male, and 48 were female. There were no significant differences in developmental levels between males and females in the five domains of gross motor skills, fine motor skills, language, personal-social skills, and adaptive behavior (P>0.05). The incidence rates of mild, moderate, severe, and profound developmental disabilities among children of different age groups showed no significant differences (P>0.05). Comparisons of developmental levels in gross motor skills, language, personal-social skills, and adaptive behavior among different age groups were also not statistically significant (P>0.05). With the increase of age, the developmental level of fine motor skills showed a decreasing trend (P<0.05). There were no significant differences in verbal IQ and non-verbal IQ within each age group of WS children (P>0.05).
Conclusions: The overall developmental level of WS children stabilizes with age, and their early language abilities do not significantly exceed their non-verbal abilities.
{"title":"[Characteristics of early cognitive development in children with Williams syndrome: a prospective cohort study].","authors":"Dan Yao, Fang-Fang Li, Ji-Yang Shen, Wei-Jun Chen, Chai Ji","doi":"10.7499/j.issn.1008-8830.2404029","DOIUrl":"10.7499/j.issn.1008-8830.2404029","url":null,"abstract":"<p><strong>Objectives: </strong>To investigate the early cognitive development characteristics of children with Williams syndrome (WS) at different age stages.</p><p><strong>Methods: </strong>From September 2018 to June 2023, 106 children diagnosed with WS at the Department of Pediatric Health Care, Children's Hospital, Zhejiang University School of Medicine, aged 1 to <5 years, were prospectively enrolled. All children underwent Gesell developmental diagnostic assessments to analyze the cognitive development characteristics of WS children across different age groups.</p><p><strong>Results: </strong>The average age of the 106 WS children was (3.1±1.2) years; 58 were male, and 48 were female. There were no significant differences in developmental levels between males and females in the five domains of gross motor skills, fine motor skills, language, personal-social skills, and adaptive behavior (<i>P</i>>0.05). The incidence rates of mild, moderate, severe, and profound developmental disabilities among children of different age groups showed no significant differences (<i>P</i>>0.05). Comparisons of developmental levels in gross motor skills, language, personal-social skills, and adaptive behavior among different age groups were also not statistically significant (<i>P</i>>0.05). With the increase of age, the developmental level of fine motor skills showed a decreasing trend (<i>P</i><0.05). There were no significant differences in verbal IQ and non-verbal IQ within each age group of WS children (<i>P</i>>0.05).</p><p><strong>Conclusions: </strong>The overall developmental level of WS children stabilizes with age, and their early language abilities do not significantly exceed their non-verbal abilities.</p>","PeriodicalId":39792,"journal":{"name":"中国当代儿科杂志","volume":"26 10","pages":"1053-1057"},"PeriodicalIF":0.0,"publicationDate":"2024-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11527411/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142523298","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-10-15DOI: 10.7499/j.issn.1008-8830.2405043
Jie Song, Yi-Lin Wang, Jia-Qi Chu
Objectives: To investigate the relationship of cerebrospinal fluid and serum levels of soluble interleukin-2 receptor (SIL-2R), endothelial nitric oxide synthase (eNOS), and cluster of differentiation 93 (CD93) with the progression and prognosis of viral encephalitis (VE) in children.
Methods: Prospectively, 102 children with VE admitted from January 2021 to January 2024 were selected as the VE group. The patients were divided into a mild subgroup (64 patients) and a severe subgroup (38 patients) according to disease progression. The patients were also divided into a good prognosis subgroup (29 patients) and a poor prognosis subgroup (73 patients) according to prognosis. A control group of 102 children with central nervous system diseases who were examined and found not to have VE during the same period was selected. The factors contributing to the poor prognosis of children with VE and the predictive value of SIL-2R, eNOS, and CD93 in cerebrospinal fluid and serum for the poor prognosis of children with VE were evaluated.
Results: Cerebrospinal fluid and serum SIL-2R, eNOS, and CD93 levels were significantly increased in the VE group, severe subgroup, and poor prognosis subgroup (P<0.05). Multivariate logistic regression analysis showed that high SIL-2R, eNOS, and CD93 levels in cerebrospinal fluid and serum were risk factors for poor prognosis in children with VE (P<0.05). Receiver operating characteristic curve analysis showed that the combination of cerebrospinal fluid SIL-2R, eNOS, and CD93 was superior to these individual indicators in prediction of poor prognosis in children with VE (P<0.05). Similarly, the combination of serum SIL-2R, eNOS, and CD93 was superior to these individual indicators in prediction of poor prognosis in children with VE (P<0.05).
Conclusions: The cerebrospinal fluid and serum levels of SIL-2R, eNOS, and CD93 are significantly elevated in children with VE, and they are associated with VE progression and prognosis.
研究目的研究脑脊液和血清中可溶性白细胞介素-2受体(SIL-2R)、内皮一氧化氮合酶(eNOS)和分化簇93(CD93)水平与儿童病毒性脑炎(VE)病情进展和预后的关系:方法:前瞻性地选取2021年1月至2024年1月期间收治的102名VE患儿作为VE组。根据疾病进展情况将患者分为轻度亚组(64 例)和重度亚组(38 例)。根据预后情况,患者还被分为预后良好亚组(29 例)和预后不良亚组(73 例)。对照组为 102 名患有中枢神经系统疾病的儿童,他们在同一时期接受了检查,但未发现 VE。评估了导致 VE 患儿预后不良的因素,以及脑脊液和血清中的 SIL-2R、eNOS 和 CD93 对 VE 患儿预后不良的预测价值:结果:脑脊液和血清中的SIL-2R、eNOS和CD93水平在VE组、重症亚组和预后不良亚组(PPPPConclusions:VE患儿脑脊液和血清中的SIL-2R、eNOS和CD93水平明显升高,它们与VE的进展和预后有关。
{"title":"[Relationship of cerebrospinal fluid and serum levels of SIL-2R, eNOS, and CD93 with the progression and prognosis of viral encephalitis in children].","authors":"Jie Song, Yi-Lin Wang, Jia-Qi Chu","doi":"10.7499/j.issn.1008-8830.2405043","DOIUrl":"10.7499/j.issn.1008-8830.2405043","url":null,"abstract":"<p><strong>Objectives: </strong>To investigate the relationship of cerebrospinal fluid and serum levels of soluble interleukin-2 receptor (SIL-2R), endothelial nitric oxide synthase (eNOS), and cluster of differentiation 93 (CD93) with the progression and prognosis of viral encephalitis (VE) in children.</p><p><strong>Methods: </strong>Prospectively, 102 children with VE admitted from January 2021 to January 2024 were selected as the VE group. The patients were divided into a mild subgroup (64 patients) and a severe subgroup (38 patients) according to disease progression. The patients were also divided into a good prognosis subgroup (29 patients) and a poor prognosis subgroup (73 patients) according to prognosis. A control group of 102 children with central nervous system diseases who were examined and found not to have VE during the same period was selected. The factors contributing to the poor prognosis of children with VE and the predictive value of SIL-2R, eNOS, and CD93 in cerebrospinal fluid and serum for the poor prognosis of children with VE were evaluated.</p><p><strong>Results: </strong>Cerebrospinal fluid and serum SIL-2R, eNOS, and CD93 levels were significantly increased in the VE group, severe subgroup, and poor prognosis subgroup (<i>P</i><0.05). Multivariate logistic regression analysis showed that high SIL-2R, eNOS, and CD93 levels in cerebrospinal fluid and serum were risk factors for poor prognosis in children with VE (<i>P</i><0.05). Receiver operating characteristic curve analysis showed that the combination of cerebrospinal fluid SIL-2R, eNOS, and CD93 was superior to these individual indicators in prediction of poor prognosis in children with VE (<i>P</i><0.05). Similarly, the combination of serum SIL-2R, eNOS, and CD93 was superior to these individual indicators in prediction of poor prognosis in children with VE (<i>P</i><0.05).</p><p><strong>Conclusions: </strong>The cerebrospinal fluid and serum levels of SIL-2R, eNOS, and CD93 are significantly elevated in children with VE, and they are associated with VE progression and prognosis.</p>","PeriodicalId":39792,"journal":{"name":"中国当代儿科杂志","volume":"26 10","pages":"1072-1077"},"PeriodicalIF":0.0,"publicationDate":"2024-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11527402/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142523321","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Objectives: To explore the associations of parental smoking and alcohol consumption during the periconceptional period and their interactions with risk of congenital heart disease (CHD) in offspring.
Methods: The parents of children with simple CHD aged 0 to 1 year (n=683) were recruited as the case group, while the parents of healthy children aged 0 to 1 year (n=740) served as the control group. A case-control study was conducted, and a questionnaire was used to collect information on perinatal exposures. After controlling for relevant confounding factors using multivariate logistic regression analysis and propensity score matching, the associations of parental smoking and alcohol consumption during the periconceptional period and their interactions with CHD were examined, as well as the cumulative effects of smoking and drinking on CHD risk.
Results: Maternal active smoking (OR=2.91, 95%CI: 1.60-5.30), passive smoking (OR=1.94, 95%CI: 1.56-2.42), and alcohol consumption (OR=2.59, 95%CI: 1.89-3.54), as well as paternal smoking (OR=1.52; 95%CI: 1.22-1.90) and drinking (OR=1.48, 95%CI: 1.19-1.84), were associated with an increased risk of CHD in offspring. There was no interaction between parental smoking and drinking behaviors during the periconceptional period concerning the risk of CHD in offspring (P>0.05). The more parents' smoking and drinking behaviors during the perinatal pregnancy, the higher the risk of CHD in their offspring (OR=1.50, 95%CI: 1.36-1.65).
Conclusions: Parental smoking and alcohol consumption during the periconceptional period are associated with the occurrence of CHD in offspring, and there is a cumulative effect on CHD risk, suggesting that reducing tobacco and alcohol exposure during the periconceptional period may lower the incidence of CHD.
{"title":"[A case-control study on the associations of parental smoking and alcohol consumption during the periconceptional period and their interactions with risk of congenital heart disease in offspring].","authors":"Liu-Xuan Li, Man-Jun Luo, Xiao-Rui Ruan, Han-Jun Liu, Jia-Peng Tang, Gui-Hong Yang, Jia-Bi Qin","doi":"10.7499/j.issn.1008-8830.2404116","DOIUrl":"10.7499/j.issn.1008-8830.2404116","url":null,"abstract":"<p><strong>Objectives: </strong>To explore the associations of parental smoking and alcohol consumption during the periconceptional period and their interactions with risk of congenital heart disease (CHD) in offspring.</p><p><strong>Methods: </strong>The parents of children with simple CHD aged 0 to 1 year (<i>n</i>=683) were recruited as the case group, while the parents of healthy children aged 0 to 1 year (<i>n</i>=740) served as the control group. A case-control study was conducted, and a questionnaire was used to collect information on perinatal exposures. After controlling for relevant confounding factors using multivariate logistic regression analysis and propensity score matching, the associations of parental smoking and alcohol consumption during the periconceptional period and their interactions with CHD were examined, as well as the cumulative effects of smoking and drinking on CHD risk.</p><p><strong>Results: </strong>Maternal active smoking (<i>OR</i>=2.91, 95%<i>CI</i>: 1.60-5.30), passive smoking (<i>OR</i>=1.94, 95%<i>CI</i>: 1.56-2.42), and alcohol consumption (<i>OR</i>=2.59, 95%<i>CI</i>: 1.89-3.54), as well as paternal smoking (<i>OR</i>=1.52; 95%<i>CI</i>: 1.22-1.90) and drinking (<i>OR</i>=1.48, 95%<i>CI</i>: 1.19-1.84), were associated with an increased risk of CHD in offspring. There was no interaction between parental smoking and drinking behaviors during the periconceptional period concerning the risk of CHD in offspring (<i>P</i>>0.05). The more parents' smoking and drinking behaviors during the perinatal pregnancy, the higher the risk of CHD in their offspring (<i>OR</i>=1.50, 95%<i>CI</i>: 1.36-1.65).</p><p><strong>Conclusions: </strong>Parental smoking and alcohol consumption during the periconceptional period are associated with the occurrence of CHD in offspring, and there is a cumulative effect on CHD risk, suggesting that reducing tobacco and alcohol exposure during the periconceptional period may lower the incidence of CHD.</p>","PeriodicalId":39792,"journal":{"name":"中国当代儿科杂志","volume":"26 10","pages":"1019-1026"},"PeriodicalIF":0.0,"publicationDate":"2024-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11527417/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142523293","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-10-15DOI: 10.7499/j.issn.1008-8830.2404133
Xin Qin, Xiao-Peng Zhao, Hua-Yan Zhang
Objectives: To investigate the levels of intrinsic positive end-expiratory pressure (PEEPi) in infants with severe bronchopulmonary dysplasia (sBPD) and the relationship between different levels of PEEPi and clinical outcomes.
Methods: A retrospective analysis was conducted on the clinical data of 12 sBPD infants who underwent PEEPi measurement and were hospitalized at Guangzhou Women and Children's Medical Center from January 2022 to June 2023. The clinical manifestations and outcomes at discharge were compared between infants with very high PEEPi (≥10 cmH2O) and those with lower PEEPi (<10 cmH2O).
Results: PEEPi measurements were taken in 12 sBPD infants between gestational age 31+3 and 67+2 weeks postmenstrual age, with the lowest PEEPi measured at 0.9 cmH2O and the highest at 19.6 cmH2O; 50% (6/12) of the infants had PEEPi ≥10 cmH2O. All infants with very high PEEPi exhibited ineffective triggering and patient-ventilator asynchrony. Among them, 5 infants could not be weaned off invasive ventilation, resulting in 4 deaths and 1 infant being discharged with a tracheostomy and ventilator support. In contrast, among the infants with PEEPi <10 cmH2O, only 1 infant died, while the others were successfully extubated and discharged.
Conclusions: Infants with sBPD may have elevated PEEPi levels, and very high PEEPi may be associated with adverse outcomes in these patients.
{"title":"[Measurement of intrinsic positive end-expiratory pressure and clinical outcomes of infants with severe bronchopulmonary dysplasia].","authors":"Xin Qin, Xiao-Peng Zhao, Hua-Yan Zhang","doi":"10.7499/j.issn.1008-8830.2404133","DOIUrl":"10.7499/j.issn.1008-8830.2404133","url":null,"abstract":"<p><strong>Objectives: </strong>To investigate the levels of intrinsic positive end-expiratory pressure (PEEPi) in infants with severe bronchopulmonary dysplasia (sBPD) and the relationship between different levels of PEEPi and clinical outcomes.</p><p><strong>Methods: </strong>A retrospective analysis was conducted on the clinical data of 12 sBPD infants who underwent PEEPi measurement and were hospitalized at Guangzhou Women and Children's Medical Center from January 2022 to June 2023. The clinical manifestations and outcomes at discharge were compared between infants with very high PEEPi (≥10 cmH<sub>2</sub>O) and those with lower PEEPi (<10 cmH<sub>2</sub>O).</p><p><strong>Results: </strong>PEEPi measurements were taken in 12 sBPD infants between gestational age 31<sup>+3</sup> and 67<sup>+2</sup> weeks postmenstrual age, with the lowest PEEPi measured at 0.9 cmH<sub>2</sub>O and the highest at 19.6 cmH<sub>2</sub>O; 50% (6/12) of the infants had PEEPi ≥10 cmH<sub>2</sub>O. All infants with very high PEEPi exhibited ineffective triggering and patient-ventilator asynchrony. Among them, 5 infants could not be weaned off invasive ventilation, resulting in 4 deaths and 1 infant being discharged with a tracheostomy and ventilator support. In contrast, among the infants with PEEPi <10 cmH<sub>2</sub>O, only 1 infant died, while the others were successfully extubated and discharged.</p><p><strong>Conclusions: </strong>Infants with sBPD may have elevated PEEPi levels, and very high PEEPi may be associated with adverse outcomes in these patients.</p>","PeriodicalId":39792,"journal":{"name":"中国当代儿科杂志","volume":"26 10","pages":"1034-1039"},"PeriodicalIF":0.0,"publicationDate":"2024-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11527413/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142523318","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}